Analytical Sciences, MRL, Merck & Co., Inc., Rahway, New Jersey 07065.
Biopharmaceutics & Specialty Dosage Form, MRL, Merck & Co., Inc., West Point, Pennsylvania 19486.
J Pharm Sci. 2019 Jan;108(1):574-583. doi: 10.1016/j.xphs.2018.10.051. Epub 2018 Nov 3.
Solubility, dissolution, and precipitation in the gastrointestinal tract can be critical for the oral bioavailability of weakly basic drugs. To understand the dissolution and precipitation during the transfer out of the stomach into the intestine, a multicompartment transfer system was developed by modifying a conventional dissolution system. This transfer system included gastric, intestinal, sink and supersaturation, and reservoir compartments. Simulated gastric fluid and fasted state simulated intestinal fluid were used in the gastric and intestinal compartment, respectively, to mimic fasted condition. The new transfer system was evaluated based on 2 model weak bases, dipyridamole and ketoconazole. Traditional 2-stage dissolution using 250 mL of simulated gastric fluid media, followed by 250 mL of fasted state simulated intestinal fluid, was used as a reference methodology to compare dissolution and precipitation results. An in silico model was built using R software suite to simulate the in vitro time-dependent dissolution and precipitation process when formulations were tested using the transfer system. The precipitation rate estimated from the in vitro data was then used as the input for absorption and pharmacokinetic predictions using GastroPlus. The resultant simulated plasma concentration profiles were generally in good agreement with the observed clinical data, supporting the translatability of the transfer system in vitro precipitation kinetics to in vivo.
在胃肠道中的溶解度、溶解和沉淀对于弱碱性药物的口服生物利用度可能至关重要。为了了解从胃转移到肠过程中的溶解和沉淀情况,通过对常规溶解系统进行修改,开发了一种多隔室传递系统。该传递系统包括胃、肠、吸收池和过饱和以及储库隔室。模拟胃液和空腹状态模拟肠液分别用于胃和肠隔室,以模拟空腹条件。该新的传递系统基于 2 种模型弱碱(双嘧达莫和酮康唑)进行了评估。使用 250 mL 模拟胃液介质的传统 2 阶段溶解,随后是 250 mL 空腹状态模拟肠液,作为参考方法用于比较溶解和沉淀结果。使用 R 软件套件构建了一个计算模型,以模拟在使用传递系统测试制剂时,体外时变溶解和沉淀过程。然后,将从体外数据估计的沉淀速率用作使用 GastroPlus 进行吸收和药代动力学预测的输入。所得模拟血浆浓度曲线通常与观察到的临床数据吻合良好,支持了传递系统在体外沉淀动力学向体内的可转化性。